Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2010 | 06-2010 | 03-2010 | 12-2009 | |
Operating Expenses | 510 | 660 | 318 | 0 |
Operating Income | -510 | -660 | -318 | N/A |
Interest Expense | 1,266 | 1,469 | 1,570 | 0 |
Other Income | 0 | 1 | 0 | 0 |
Pre-tax Income | -1,776 | -2,128 | -1,888 | 0 |
Net Income Continuous | -1,776 | -2,128 | -1,888 | N/A |
Net Income | $-1,776 | $-2,128 | $-1,888 | $N/A |
EPS Basic Total Ops | -238.30 | -285.71 | -252.10 | N/A |
EPS Basic Continuous Ops | -238.52 | -285.73 | -253.46 | N/A |
EPS Diluted Total Ops | -238.30 | -285.71 | -252.10 | N/A |
EPS Diluted Continuous Ops | -238.52 | -285.73 | -253.46 | N/A |
EBITDA(a) | $424 | $490 | $-91 | $N/A |